News & Events

HTG Molecular to Present Corporate Overview at the Cantor 2019 Global Healthcare Conference

TUCSON, Ariz. , Sept. 30, 2019 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a diagnostic company whose mission is to advance precision medicine, today announced that John Lubniewski , President and CEO, will present a corporate overview at the Cantor 2019 Global

full press release

Posted on:

Return To List

Page last updated